These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Towards the individualisation of prescriptions in oncology: urogenital cancers].
    Author: Pouessel D, Culine S.
    Journal: Bull Cancer; 2008 Oct; 95(10):975-8. PubMed ID: 19004728.
    Abstract:
    The daily management of urogenital cancers is currently based on prognostic classifications derived from the identification of independent clinical or biological indicators of overall survival. These classifications are used for patient stratification in clinical trials and definition of appropriate strategies according to prognostic groups. Their knowledge is therefore essential for optimizing treatment decisions. Metastatic germ cell tumours and renal cell cancers as well as localised prostate cancers are classical models for the development of such classifications. The emergence of targeted therapies and the identification of predictive parameters for treatment efficacy should represent a further step towards the emergence of individualized treatments in the near future.
    [Abstract] [Full Text] [Related] [New Search]